wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33371232-F806ECDF-5773-4676-80AD-1899DB2634DF
Q33371232-F806ECDF-5773-4676-80AD-1899DB2634DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33371232-F806ECDF-5773-4676-80AD-1899DB2634DF
Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors.
P478
Q33371232-F806ECDF-5773-4676-80AD-1899DB2634DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33371232-F806ECDF-5773-4676-80AD-1899DB2634DF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c8c72611f56e408784d509d5d0d8eb23588dec2f
P478
12
http://www.w3.org/2001/XMLSchema#string